Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals company information, Employees & Contact Information

Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management to a focus on rapid-acting and durable therapies targeting the fundamental drivers of disease. We do this by designing best-in-class new chemical entities (NCEs) acting through proven mechanisms, which are optimized for safety, efficacy, and patient access

Company Details

Employees
34
Founded
-
Address
113 University Pl,
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Provider jobs.
HQ
New York, New York
Looking for a particular Gilgamesh Pharmaceuticals employee's phone or email?

Gilgamesh Pharmaceuticals Questions

News

Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance Novel, Cardiac-Safe Ibogaine Analog for the Treatment of Opioid Use Disorder - PR Newswire

Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance Novel, Cardiac-Safe Ibogaine Analog for the Treatment of Opioid Use Disorder PR Newswire

21.6-Point Depression Score Improvement: AbbVie Acquires Breakthrough Short-Acting Psychedelic Drug - Stock Titan

21.6-Point Depression Score Improvement: AbbVie Acquires Breakthrough Short-Acting Psychedelic Drug Stock Titan

Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments - Psychedelic Alpha

Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments Psychedelic Alpha

Gilgamesh Pharma to Webcast Live at VirtualInvestorConferences.com April 28th - GlobeNewswire

Gilgamesh Pharma to Webcast Live at VirtualInvestorConferences.com April 28th GlobeNewswire

Gilgamesh Appoints New Members to Board of Directors - citybiz

Gilgamesh Appoints New Members to Board of Directors citybiz

Gilgamesh Pharmaceuticals Announces Positive Topline Phase 2a Results for GM-2505 in Major Depressive Disorder (MDD) - PR Newswire

Gilgamesh Pharmaceuticals Announces Positive Topline Phase 2a Results for GM-2505 in Major Depressive Disorder (MDD) PR Newswire

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round - Psychedelic Alpha

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round Psychedelic Alpha

Top Gilgamesh Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant